Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study

Werfel, Thomas; Breuer, Kristine; Ruëff, Franziska; Przybilla, Bernhard; Worm, Margitta; Grewe, Markus; Ruzícka, T.; Brehler, Randolf; Wolf, Hendrik; Schnitker, J; Kapp, Alexander

doi:10.1111/j.1398-9995.2006.00974.x

Cited by 248 publications

(175 citation statements)

References 11 publications

Supporting

Mentioning

154

Contrasting

Unclassified

Order By: Relevance

“…A recently published study, re-examining the efficacy of a subcutaneous immunotherapy (SCIT) in atopic patients sensitized to house dust mites, demonstrated effectiveness in reducing eczema and allergic sensitization to HDM 97 .…”

Section: ) Immunotherapymentioning

confidence: 99%

Atopic Dermatitis

2010

View full text Add to dashboard Cite

Section: ) Immunotherapymentioning

confidence: 99%

Atopic Dermatitis

2010

View full text Add to dashboard Cite

“…Two controlled SCIT studies for dust mite allergic patients with AD have been published. 163,164 Long-term treatment with high dose SCIT produced statistically significant improvement in AD in both groups. One controlled SLIT study has shown skin improvement in dust mite allergic children with AD.…”

Section: Specific Immunotherapy (Sit)mentioning

confidence: 97%

Clinical correlations of recent developments in the pathogenesis of atopic dermatitis

Sehra

Tuana

Holbreich

et al. 2008

An. Bras. Dermatol.

View full text Add to dashboard Cite

Atopic dermatitis is a chronic inflammatory skin disease with a steadily increasing prevalence affecting 10-20 % of infants and 1-3% of adults globally. It is often the first clinical manifestation of atopic disease preceding asthma and allergic rhinitis. Probably half of the children with atopic dermatitis develop some other form of atopic disease later in life. The pathogenesis involves a complex interplay of factors including genetic predisposition due to altered immune or skin barrier function, interactions with the environment such as food and allergen exposures, and infectious triggers of inflammation. In this review, we summarize the recent advances in understanding the contribution of different factors in the pathophysiology of atopic dermatitis and how insights provide new therapeutic potential for its treatment. Keywords: Asthma; Atopic Dermatitis, Eczema; Eosinophils; Genetics; Immunoglobulin E; Keratinocytes; Rhinitis, T-Lymphocytes Resumo: A dermatite atópica é uma doença cutânea inflamatória crônica cuja prevalência tem aumentado de forma constante, afetando 10-20% dos lactentes e 1-3% dos adultos em todo o mundo. Ela é freqüentemente a primeira manifestação clínica de doença atópica, precedendo a asma e a rinite alérgica. Provavelmente metade das crianças com dermatite atópica desenvolvem alguma

show abstract

“…En las últimas dos décadas, se han llevado a cabo varios estudios aleatorios controlados en los cuales se ha demostrado que un porcentaje importante de los pacientes con dermatitis atópica se puede beneficiar con esta terapia, aunque su impacto varía de acuerdo con la gravedad de la enfermedad (57)(58)(59)(60)(61). En un estudio en Medellín, Colombia, se observó que los pacientes con dermatitis moderada según la puntuación en el Scoring Atopic Dermatitis (SCORAD), tuvieron una mayor y más significativa reducción de los síntomas en comparación con el grupo placebo, así como un aumento significativo de la IgG4 (62) y una disminución en la capacidad de activación de los basófilos (25), lo que indicaría una disminución sostenida de la reacción inflamatoria.…”

Section: Dermatitis Atópicaunclassified

Inmunoterapia con alérgenos: mecanismos de acción, impacto terapéutico y socioeconómico. Consenso de la Asociación Colombiana de Alergias Asma e Inmunología

et al. 2016

View full text Add to dashboard Cite

: idea central. Todos los autores participaron por igual en la redacción del manuscrito y la aprobaron la versión final. Las alergias constituyen un conjunto de enfermedades de gran prevalencia. Cuando los procesos alérgicos no se controlan, pueden poner en peligro la salud e, incluso, la vida de los pacientes y, además, su efecto económico y social es considerable. El objetivo de esta revisión es presentar un consenso práctico de la información científica disponible sobre el empleo de la inmunoterapia en las enfermedades alérgicas con la colaboración de varios institutos y universidades de Colombia, por solicitud de la Asociación Colombiana de Alergia, Asma e Inmunología. La revisión incluyó aspectos prácticos presentados desde el punto de vista de médicos generales, alergólogos, inmunólogos, internistas y pediatras con experiencia en el campo de las alergias. Con base en la evidencia científica actual a nivel nacional e internacional, se describió de forma detallada en qué consiste la inmunoterapia, sus indicaciones, contraindicaciones y sus beneficios para la salud, así como en el ámbito socioeconómico. Se concluyó que la inmunoterapia es efectiva y segura, y que, además, puede reducir sustancialmente el costo del tratamiento global de los pacientes alérgicos. Inmunoterapia con alérgenosPalabras clave: alérgenos, consenso, asma, anafilaxia, dermatitis, conjuntivitis, himenópteros, inmunoterapia, rinitis.doi: http://dx.doi.org/10.7705/biomedica.v36i3.3183 Allergen immunotherapy: Mechanisms of action, and therapeutic and socioeconomic impact Consensus of the Asociación Colombiana de Alergia, Asma e ImunologíaAllergies comprise a set of highly prevalent diseases. When allergic processes are not controlled, they can endanger patients' health and lives, and have an important economic and social impact. The aim of this paper is to present a practical consensus of the scientific evidence on the use of immunotherapy in allergic diseases. A collaborative review made by various institutes and universities in Colombia was carried out upon request of the Asociación Colombiana de Alergia, Asma e Imunología, led by general practitioners, allergists, immunologists, internists and paediatricians with experience in the field of allergies. As a result, based on current national and international scientific evidence, we describe in detail what immunotherapy is about, its indications, contraindications and its economic and health benefits.Conclusions show immunotherapy as a clinically effective and safe treatment, which can substantially reduce the cost of the overall treatment of allergic patients.

show abstract

Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study

Abstract: Allergen-SIT for 1 year with a house dust mite preparation is able to improve the eczema in patients with atopic dermatitis who are sensitized to house dust mite allergens and reduces the need for topical corticosteroids. SIT may be valuable in the treatment of this chronic skin disease.

Cited by 248 publications

References 11 publications

Atopic Dermatitis

Atopic Dermatitis

Clinical correlations of recent developments in the pathogenesis of atopic dermatitis

Inmunoterapia con alérgenos: mecanismos de acción, impacto terapéutico y socioeconómico. Consenso de la Asociación Colombiana de Alergias Asma e Inmunología

Contact Info

Product

Resources

About